Monetary Stimulus = Currency Devaluation = Increasing Gold Demand

As the world starts to emerge from the first wave of the COVID-19 crisis, the implications for the unprecedented monetary stimulus measures employed by Governments around the globe to support citizens in lockdown are becoming ever clearer. As stock markets roar back from the coronavirus-led rout, advisers to the world’s wealthy are urging them to […]

Open Orphan #ORPH – Positive Phase 1 study results published in The Lancet

Monday 15th June, 2020 Positive results from the Phase I study of the AGS-v vaccine developed by an Open Orphan joint venture, Imutex Limited, have been published in the peer reviewed journal The Lancet AGS-v is a first-in-class mosquito saliva, standalone, vaccine candidate designed to protect against mosquito-borne diseases carried in the saliva such as Zika, Malaria, […]

Experts seek approval for COVID-19 trials – China Daily

By ANGUS McNEICE in London Medical community divided on issue of exposing humans to deadly virus A laboratory in the United Kingdom is hoping to become the first in the world to intentionally infect volunteers with novel coronavirus in order to test the efficacy of COVID-19 vaccines. Half of the participants in these so-called human […]

Open Orphan plc #ORPH – Launch of Covid-19 Antibody Testing

Open Orphan plc      (“Open Orphan” or the “Company”) Launch of Covid-19 Antibody Testing Open Orphan plc (ORPH), a rapidly growing specialist CRO pharmaceutical services company which is the world leader in the testing of vaccines and antivirals using human challenge study models, announces the launch of hVIVO COVID Clear Test, the Company’s antibody testing […]

Open Orphan #ORPH – Results of Fundraising

Open Orphan plc (ORPH), a rapidly growing specialist CRO pharmaceutical services company which has a focus on orphan drugs and is the world leader in the testing of vaccines and antivirals using human challenge study models, announces that, further to its announcement at 7.00 a.m. today (the “Fundraising Announcement”), it has successfully completed the oversubscribed […]

Open Orphan #ORPH – Update on antibody test agreement and recent share price movement

Open Orphan plc (ORPH) the rapidly growing specialist CRO pharmaceutical services company which has a focus on orphan drugs and is the world leader in the testing of vaccines and antivirals using human challenge study models, notes the increase in the Company’s share price and media comment regarding its collaboration with Quotient Limited. Furthermore, it […]

Mirriad Advertising #MIRI – Preliminary Results for the year ended 31 December 2019

Mirriad Advertising plc, the computer vision and AI platform company, announces its unaudited results for the year ended 31 December 2019.   Financial overview ·    2019 revenue of £1,140k (2018 £416k) ·    Operating loss reduced 16% to £12.2m (2018: £14.4m) ·    Net assets £19.2m (2018: £15.6m) ·    Cash and cash equivalents at 31 December 2019 […]